| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.1 |